Effects of a Walking Intervention in Older Patients With Chronic Kidney Disease: Feasibility Study

Not Applicable

Completed

• Conditions: Chronic Kidney Disease
• Interventions: Behavioral: walking

• Registration Number: NCT02155127
• Lead Sponsor: University of Utah

Brief Summary

Chronic kidney disease (CKD) affects more than 26 million individuals (13 percent) of the U.S. population, with a projected 70 percent increase by the year 2015 to over 40 million individuals. Impairments in physical function and mobility limitations have been reported in older Chronic Kidney Disease patients, however the consequences of impaired functioning on participation in daily life and quality of life have not been studied. Early identification and interventions to mitigate deterioration in physical function and mobility should lead to improved health and quality of life outcomes in older patients with Chronic Kidney Disease. Although older individuals with Chronic Kidney Disease have reduced survival expectancy, maintaining physical function and mobility may contribute to longer active life expectancy, and higher quality of life despite their diagnosis.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2014-06-02
• Study First Submitted QC: 2014-06-02
• Study First Posted: 2014-06-04
• Study Start: 2014-10
• Primary Completion: 2016-10
• Study Completion: 2016-10
• Status Verified: 2016-11
• Last Update Submitted: 2016-11-16
• Last Update Posted: 2016-11-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Male and female patients over the age of 60 years
• Diagnosed with moderate to severe CKD (stage 2-4)
• Ambulatory (with or without use of an assistive device such as a cane or walker)
• Living in the community, cognitively able to provide consent and understand directions for the tests
• Cognitive ability to understand and carry out an independent home walking program
• Access and ability to communicate with study staff on a weekly basis and available for follow-up testing.

Read More

Exclusion Criteria

• Inability to carry out a program of walking independently at home
• Unavailable for follow-up testing, estimated GFR >60 ml/minx1.73m2 and < 15 ml/minx1.73 m2
• Recent cardiac event (within the past 6 months)
• Uncontrolled hypertension
• Uncontrolled diabetes
• Pulmonary disease that may limit the ability to progress with walking
• Progressive neuromuscular disease
• Any orthopedic or neuromuscular condition that may be exacerbated by increased walking activity
• diabetic foot ulcer.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
walking intervention	walking	Subjects are randomized to walking/functional strength program with weekly coaching or usual care. The program is for 12 weeks. The intervention includes 3 lower extremity strengthening exercises, and progressive walking.

Primary Outcome Measures

Name	Time	Method
walking speed	baseline to 3 months

Trial Locations

Locations (1)

University of Utah; 🇺🇸 Salt Lake City, Utah, United States